JCP Weekly July 17, 2018

Academic Highlights

Perspectives on the New FDA Pregnancy and Lactation Labeling Rule

Pregnancy labeling of prescription medications in the US is in the midst of a major transformation. Are you aware of the changes? Read this summary of a recent conference including representatives from academia, industry, and the goverment to bring yourself up to date on the new labeling system.

DOI: 10.4088/JCP.18ah38120 | Posted: 07/17/2018

Clinical and Practical Psychopharmacology

Congenital Malformations Associated With Antiepileptic Drugs

Which antiepileptic drugs present the greatest risks during pregnancy? In this installment of Clinical and Practical Psychopharmacology, Dr Andrade looks at the evidence to determine the drugs associated with the greatest potential danger to the fetus, as well as the ones that seem to pose no added risk.

DOI: 10.4088/JCP.18f12449 | Posted: 07/17/2018

Original Research

Screening Tools in Collaborative Care of Depression

Could collaborative care be especially beneficial in certain youth with depression? Researchers enrolled patients in a collaborative care treatment model and then looked at program graduation rates in light of baseline scores on depression, anxiety, and substance use assessments. Read this CME selection and see if they were able to identify predictors of remission.

DOI: 10.4088/JCP.17m11543 | Posted: 07/17/2018

See past JCP Weekly